| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC serves as a 10% Owner at HIND and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 337 buys and 114 sells. Those positions are worth an estimated $10.1M at current prices.
Historically, Armistice Capital, LLC's trades have earned a middling insider score of 56/100 across 42 rated trades. Over a 12-month horizon, 23.8% of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is ACHV (~$3.7M) as 10% Owner. The recent filings there lean toward selling, a net 299,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2020 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 100,000 | $2.37 | $236,868.64 | +0.3% | |
| Sep 8, 2020 | TENX Tenax Therapeutics, Inc. | Director, 10% Owner | Buy | 32,000 | $1.42 | $45,547.15 | +1.6% | |
| Sep 4, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 100,000 | $2.20 | $220,000.00 | +0.3% | |
| Sep 3, 2020 | TENX Tenax Therapeutics, Inc. | Director, 10% Owner | Buy | 86,000 | $1.43 | $123,240.00 | +4.5% | |
| Aug 31, 2020 | TENX Tenax Therapeutics, Inc. | Director, 10% Owner | Buy | 32,000 | $1.47 | $47,000.00 | +1.7% | |
| Aug 26, 2020 | TENX Tenax Therapeutics, Inc. | 10% Owner | Buy | 34,903 | $1.51 | $52,700.07 | +1.9% | |
| Aug 21, 2020 | TENX Tenax Therapeutics, Inc. | Director, 10% Owner | Buy | 311,481 | $1.48 | $460,442.79 | +20.4% | |
| Jun 29, 2020 | VXRT Vaxart, Inc. | Director | Sell | 27,612,053 | $9.67 | $266,997,653.40 | -99.5% | |
| Jun 11, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 2,049,486 | $2.50 | $5,127,391.12 | -222.4% | |
| Jun 3, 2020 | VXRT Vaxart, Inc. | Director | Sell | 1,400,000 | $2.75 | $3,856,000.00 | -16.7% |